Skip to content
PeptideAgent

Teriparatide regulatory status

Current status of Teriparatide in the United States: FDA approved. In sport: Not WADA prohibited. Details, sources, and the dated timeline follow.

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What is the current status of Teriparatide?

Regulatory: FDA approvedWADA: Not WADA prohibitedVerified: Verified Sep 23, 2026
FDA and compounding
FDA approved as Forteo in November 2002 for postmenopausal women with osteoporosis at high fracture risk, men with primary or hypogonadal osteoporosis, and glucocorticoid induced osteoporosis. A 505(b)(2) product (Bonsity, 2019) and generic teriparatide injections have since been approved. In November 2020 FDA approved label changes removing the boxed warning for osteosarcoma and the 2 year lifetime treatment limit. Because approved products exist, compounding teriparatide is not permitted except in narrow patient specific circumstances.
WADA
Not WADA prohibited
Access path
  1. Prescription from a licensed provider (usually endocrinology, rheumatology, or primary care) filled at a retail or specialty pharmacy.
  2. Prior authorization typically requires a documented fragility fracture, very low bone density, or failure of oral bisphosphonates.
  3. Not available through compounding or telehealth peptide clinics.

Full Teriparatide page: evidence, dosing in the literature, and sources

How has the status of Teriparatide changed over time?

  1. FDA

    FDA approves Forteo (teriparatide) for osteoporosis

    FDA approved teriparatide injection (Forteo), a recombinant parathyroid hormone fragment, for postmenopausal women with osteoporosis at high risk of fracture and to increase bone mass in men with primary or hypogonadal osteoporosis.

    Regulatory: FDA approvedSource: Drugs@FDA: Forteo (teriparatide) NDA 021318

Sources

Numbered citations in the answers above point here, followed by the regulatory sources on record for Teriparatide and the source of each dated event.

  1. [1]FDA prescribing information for Forteo (teriparatide injection), via DailyMedFDA, 2026
  2. [2]WADA Prohibited ListWADA, 2026
  3. [3]Drugs@FDA: Forteo (teriparatide) NDA 021318FDA, 2002